GNOM vs. EMSF ETF Comparison
Comparison of Global X Genomics & Biotechnology ETF (GNOM) to Matthews Emerging Markets Sustainable Future Active ETF (EMSF)
GNOM
Global X Genomics & Biotechnology ETF
GNOM Description
The investment seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Genomics Index ("underlying index"). The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, "Genomics & Biotechnology Companies"), as defined by Solactive AG, the provider of the underlying index. The fund is non-diversified.
Grade (RS Rating)
Last Trade
$10.08
Average Daily Volume
43,573
40
EMSF
Matthews Emerging Markets Sustainable Future Active ETF
EMSF Description
EMSF actively invests in common and preferred stocks of companies in emerging markets, including countries that may be considered frontier. While the fund has an all-cap exposure, it expects to invest substantially in smaller companies. The fund looks for sustainable growth based on fundamental characteristics such as balance sheet information, size, cash flow stability, and financial health. It also applies various ESG standards, using third-party data and the adviser's proprietary research, to identify investments that potentially contribute to a sustainable future by addressing global environmental and social challenges. The fund also employs exclusionary ESG screens, which avoid controversial businesses such as tobacco, weapons, and fossil fuels. The fund may engage its portfolio companies on sustainability and governance matters through active dialogue, exercising shareholder rights, and encouraging enhanced ESG disclosure.Grade (RS Rating)
Last Trade
$25.86
Average Daily Volume
2,360
3
Performance
Period | GNOM | EMSF |
---|---|---|
30 Days | -5.26% | -5.22% |
60 Days | -8.86% | -1.79% |
90 Days | -12.73% | -0.15% |
12 Months | -3.58% | 0.79% |
1 Overlapping Holdings
Symbol | Grade | Weight in GNOM | Weight in EMSF | Overlap | |
---|---|---|---|---|---|
LEGN | F | 3.96% | 3.91% | 3.91% |
GNOM Overweight 39 Positions Relative to EMSF
Symbol | Grade | Weight | |
---|---|---|---|
NTRA | B | 6.14% | |
VCYT | B | 5.24% | |
CRSP | D | 4.45% | |
QGEN | D | 4.33% | |
TECH | D | 4.3% | |
A | D | 4.19% | |
RNA | D | 4.17% | |
ARWR | F | 4.07% | |
BNTX | D | 3.99% | |
ILMN | D | 3.99% | |
BMRN | D | 3.88% | |
SRPT | D | 3.7% | |
RARE | D | 3.68% | |
ALNY | D | 3.66% | |
BEAM | D | 3.6% | |
MRNA | F | 3.0% | |
MYGN | F | 2.74% | |
TXG | F | 2.72% | |
NTLA | F | 2.69% | |
CDNA | D | 2.27% | |
RCKT | F | 2.24% | |
GILD | C | 2.2% | |
VRTX | F | 2.08% | |
VIR | D | 1.22% | |
MRVI | F | 1.15% | |
PACB | F | 0.91% | |
RGNX | F | 0.87% | |
SGMO | C | 0.79% | |
FLGT | F | 0.69% | |
SANA | F | 0.62% | |
VERV | F | 0.58% | |
ALLO | F | 0.57% | |
QURE | D | 0.52% | |
EDIT | F | 0.4% | |
PSTX | D | 0.36% | |
CRBU | F | 0.33% | |
TSVT | F | 0.3% | |
LYEL | F | 0.29% | |
SCLX | F | 0.01% |
GNOM: Top Represented Industries & Keywords
EMSF: Top Represented Industries & Keywords